Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Heart failure linked to heavy energy drink consumption
Fri April 16th - Drinking excessive energy drinks could be linked to a young man’s heart failure, according to doctors who treated a 21-year-old who consumed four cans a day for two years. More
Shift workers' heart health linked to body clock
Fri April 16th - The risk of heart disease becomes greater the more an individual works outside of their natural body clock, new research suggests. More
Infection much greater risk than vaccines for thrombotic events
Fri April 16th - Cerebral venous thrombosis has been a significant complication of COVID-19 at a rate far higher than seen after vaccination, British researchers have reported. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...

Self-treatment may prevent clots

Thursday December 1st, 2011

People who are taking regular drugs to prevent blood clotting fare better if they are trained to monitor their treatment themselves, British researchers say today.

In Germany about 20 per cent of patients test themselves and manage their dose levels - but in other countries the procedure is unusual.

These patients enjoy a risk of developing blood clots that is almost halved compared with those who have conventional care, according to the study, reported in The Lancet.

Researchers at Oxford University studied the results of some 11 randomised trials of self-monitoring.

They found that self-monitoring but the risk of dangerous blood clots by 49 per cent - but it did not make a difference to the overall risk of dying.

The researchers led by Carl Heneghan, from Oxford University, UK, say: "Self-monitoring and self-management of oral coagulation is a safe option for suitable patients of all ages. Patients should also be offered the option to self-manage their disease with suitable health-care support as back-up."

Writing in the journal, Paul Alexander Kyrle and Sabine Eichinger from the Medical University of Vienna, Vienna, Austria, say self-management should be used for patients with mechanical heart valves.

They add: "We do not see a place for self-monitoring in other areas of this treatment except for individual patients for whom access to routine usual anticoagulation care is restricted."

Maureen Talbot, of the British Heart Foundation, said the findings should not be seen as a "green light" for patients to treat themselves without a doctor's advice.

She said: "These results are certainly encouraging because they suggest suitable patients can self-monitor their medicine effectively, with appropriate support from a healthcare professional."

The Lancet December 1 2011 doi:10.1016/S0140-6736(11)61748-0

Tags: Europe | Heart Health | Pharmaceuticals | UK News

Printer friendly page Printer friendly page